| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman Bmj 339, 2009 | 193443* | 2009 |
| The PRISMA 2020 statement: an updated guideline for reporting systematic reviews MJ Page, JE McKenzie, PM Bossuyt, I Boutron, TC Hoffmann, CD Mulrow, ... bmj 372, 2021 | 129311 | 2021 |
| Cochrane handbook for systematic reviews of interventions JPT Higgins, S Green Wiley-Blackwell 5 (2), S38, 2008 | 80888 | 2008 |
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration A Liberati, DG Altman, J Tetzlaff, C Mulrow, PC Gøtzsche, JPA Ioannidis, ... Bmj 339, 2009 | 58040 | 2009 |
| PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation AC Tricco, E Lillie, W Zarin, KK O'Brien, H Colquhoun, D Levac, D Moher, ... Annals of internal medicine 169 (7), 467-473, 2018 | 39800 | 2018 |
| The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials JPT Higgins, DG Altman, PC Gøtzsche, P Jüni, D Moher, AD Oxman, ... bmj 343, 2011 | 36027 | 2011 |
| Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement D Moher, L Shamseer, M Clarke, D Ghersi, A Liberati, M Petticrew, ... Systematic reviews 4 (1), 1, 2015 | 25312 | 2015 |
| Meta-analysis of observational studies in epidemiology: a proposal for reporting DF Stroup, JA Berlin, SC Morton, I Olkin, GD Williamson, D Rennie, ... Jama 283 (15), 2008-2012, 2000 | 22744 | 2000 |
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, Prisma Group International journal of surgery 8 (5), 336-341, 2010 | 22317* | 2010 |
| Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation L Shamseer, D Moher, M Clarke, D Ghersi, A Liberati, M Petticrew, ... Bmj 349, 2015 | 14270 | 2015 |
| Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration JP Vandenbroucke, E Von Elm, DG Altman, PC Gøtzsche, CD Mulrow, ... International journal of surgery 12 (12), 1500-1524, 2014 | 13192 | 2014 |
| AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both BJ Shea, BC Reeves, G Wells, M Thuku, C Hamel, J Moran, D Moher, ... bmj 358, 2017 | 11440 | 2017 |
| The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials D Moher, KF Schulz, DG Altman The lancet 357 (9263), 1191-1194, 2001 | 11317* | 2001 |
| Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide TC Hoffmann, PP Glasziou, I Boutron, R Milne, R Perera, D Moher, ... Bmj 348, 2014 | 10283 | 2014 |
| The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsDeclaracion PRISMA 2020: una guia actualizada para la publicacion de revisiones sistematicas MJ Page, JE McKenzie, PM Bossuyt, I Boutron, TC Hoffmann, CD Mulrow, ... Revista panamericana de salud publica= Pan American journal of public health …, 2022 | 8450 | 2022 |
| The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations B Hutton, G Salanti, DM Caldwell, A Chaimani, CH Schmid, C Cameron, ... Annals of internal medicine 162 (11), 777-784, 2015 | 7512 | 2015 |
| Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials JAC Sterne, AJ Sutton, JPA Ioannidis, N Terrin, DR Jones, J Lau, ... Bmj 343, 2011 | 7325 | 2011 |
| SPIRIT 2013 statement: defining standard protocol items for clinical trials AW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC Gøtzsche, ... Annals of internal medicine 158 (3), 200-207, 2013 | 7061 | 2013 |
| Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement D Moher, DJ Cook, S Eastwood, I Olkin, D Rennie, DF Stroup The Lancet 354 (9193), 1896-1900, 1999 | 6263 | 1999 |
| SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials AW Chan, JM Tetzlaff, PC Gøtzsche, DG Altman, H Mann, JA Berlin, ... Bmj 346, 2013 | 5951 | 2013 |
